经颈动脉血运重建术后出血并发症的危险因素与后果:血管质量倡议分析
基于VQI数据库2017–2023年50,909例TCAR手术的回顾性分析显示,术后出血并发症总体发生率为1.9%,术中未使用鱼精蛋白是最强危险因素(aOR 3.91),出血并发症与住院延长、非计划再手术及多种非出血并发症相关。
要点
- TCAR术后出血并发症总体发生率为1.9%。
- 术中未使用鱼精蛋白者出血风险显著升高(aOR 3.91)。
- 出血并发症与住院延长及非计划再手术相关。
核心结论
- TCAR术后出血并发症罕见但可能伴随不良结局,包括全身性和神经系统后遗症。
- 出血并发症与抗凝或抗血小板方案无关,但术中鱼精蛋白与降低手术出血并发症风险相关,应在TCAR术中考虑使用。
研究设计与样本
- 回顾性查询血管质量倡议(VQI)数据库2017–2023年间所有接受TCAR的患者。
- 共纳入50,909例TCAR手术,主要结局为术后出血并发症(包括所有颈部血肿、手术出血和假性动脉瘤),采用单变量检验和多变量logistic回归分析。
主要发现
- 术后出血并发症总体发生率为1.9%。
- 最强危险因素为术中未使用鱼精蛋白(aOR 3.91 [95%CI 3.41-4.47],P<0.0001)。
- 其他危险因素包括既往颈动脉内膜切除术(aOR 1.44 [95%CI 1.18-1.75],P=0.0004)、颈部放疗(aOR 1.42 [95%CI 1.08-1.85],P=0.01)和有症状狭窄(aOR 1.19 [95%CI 1.04-1.35],P=0.009)。
- 术前和出院时抗凝药物与出血并发症无关。
- 发生出血并发症的患者住院时间更长且因出血的非计划再手术更多(两者P<0.0001);非出血并发症也更常见,包括颅神经损伤、术后卒中、再灌注损伤、心肌梗死、心律失常、颈动脉狭窄或闭塞、充血性心力衰竭加重和伤口感染(各P<0.0001)。
临床怎么用
- TCAR术中应考虑使用鱼精蛋白以降低手术出血并发症风险。
- 对既往颈动脉内膜切除术、颈部放疗或有症状狭窄的高危患者应加强术后出血监测。
- 出血并发症患者需警惕伴随的颅神经损伤、卒中、心肌梗死等非出血并发症。
局限性
- 回顾性数据库研究设计。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Previous case series on postoperative bleeding complications after transcarotid artery revascularization (TCAR) have primarily been through case series. The purpose of this study is to evaluate risk factors and consequences of bleeding complications after TCAR on a national level. METHODS: The Vascular Quality Initiative database was retrospectively queried for all patients undergoing TCAR between 2017 and 2023. The primary outcome of interest was postoperative bleeding complications, which included all neck hematomas, surgical bleeding, and pseudoaneurysms. Univariate tests and multivariable logistic regression analyses were utilized. RESULTS: A total of 50,909 TCAR procedures were included. The overall incidence of bleeding complications was 1.9%. The strongest risk factor for postoperative bleeding complications was lack of intraoperative protamine (adjusted odds ratio [aOR] 3.91 [95% confidence interval [CI], 3.41-4.47], P < 0.0001). Other risk factors included prior carotid endarterectomy (aOR 1.44 [95% CI, 1.18-1.75], P = 0.0004), neck radiation (aOR 1.42 [95% CI, 1.08-1.85], P = 0.01), and symptomatic stenosis (aOR 1.19 [95% CI, 1.04-1.35], P = 0.009). Preoperative and discharge anticoagulants (AC) were not associated with bleeding complications. Patients suffering postoperative bleeding complications had a longer index hospitalization and more unplanned reoperations for bleeding (P < 0.0001 both). Nonbleeding complications were also more common among patients suffering bleeding complications, including cranial nerve injury, postoperative stroke, reperfusion injury, myocardial infarction, dysrhythmia, carotid stenosis or occlusion, congestive heart failure exacerbation, and wound infection (P < 0.0001 each). CONCLUSION: Postoperative bleeding complications are rare after TCAR and may be associated with adverse outcomes, including systemic and neurologic sequelae. Bleeding complications are not associated with AC or antiplatelet regimen. However, intraoperative protamine is associated with reduced risk of surgical bleeding complications, and should be considered during TCAR operations.
引用
- Cui CL, Pride LB, West-Livingston LN, et al. Risk Factors and Consequences of Bleeding Complications after Transcarotid Artery Revascularization in the Vascular Quality Initiative. Ann Vasc Surg. 2025. PMID: 40645568. doi:10.1016/j.avsg.2025.07.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。